ATE483809T1 - Nicht spaltbare hcmv gb proteine - Google Patents
Nicht spaltbare hcmv gb proteineInfo
- Publication number
- ATE483809T1 ATE483809T1 AT05075216T AT05075216T ATE483809T1 AT E483809 T1 ATE483809 T1 AT E483809T1 AT 05075216 T AT05075216 T AT 05075216T AT 05075216 T AT05075216 T AT 05075216T AT E483809 T1 ATE483809 T1 AT E483809T1
- Authority
- AT
- Austria
- Prior art keywords
- hcmv
- proteins
- flexible
- glycoprotein
- hsv
- Prior art date
Links
- 241000701024 Human betaherpesvirus 5 Species 0.000 title abstract 2
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 102000003886 Glycoproteins Human genes 0.000 abstract 2
- 108090000288 Glycoproteins Proteins 0.000 abstract 2
- 108020001507 fusion proteins Proteins 0.000 abstract 1
- 102000037865 fusion proteins Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/01—DNA viruses
- C07K14/03—Herpetoviridae, e.g. pseudorabies virus
- C07K14/035—Herpes simplex virus I or II
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
- C12N2710/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
- C12N2710/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Plant Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physics & Mathematics (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9409962A GB9409962D0 (en) | 1994-05-18 | 1994-05-18 | Novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE483809T1 true ATE483809T1 (de) | 2010-10-15 |
Family
ID=10755348
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95919447T ATE293697T1 (de) | 1994-05-18 | 1995-05-11 | Fusion-glykoprotein von hcmv und hsv |
| AT05075216T ATE483809T1 (de) | 1994-05-18 | 1995-05-11 | Nicht spaltbare hcmv gb proteine |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95919447T ATE293697T1 (de) | 1994-05-18 | 1995-05-11 | Fusion-glykoprotein von hcmv und hsv |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US5889168A (de) |
| EP (2) | EP0759995B1 (de) |
| JP (1) | JPH10500009A (de) |
| KR (1) | KR970703428A (de) |
| AT (2) | ATE293697T1 (de) |
| AU (1) | AU2527195A (de) |
| BR (1) | BR9507728A (de) |
| CA (1) | CA2190529A1 (de) |
| CY (1) | CY2597B2 (de) |
| DE (2) | DE69536112D1 (de) |
| DK (1) | DK0759995T3 (de) |
| ES (2) | ES2353134T3 (de) |
| GB (1) | GB9409962D0 (de) |
| HK (1) | HK1012415A1 (de) |
| HU (1) | HU9603163D0 (de) |
| NO (1) | NO964874D0 (de) |
| PL (1) | PL317235A1 (de) |
| PT (1) | PT759995E (de) |
| SI (1) | SI0759995T1 (de) |
| WO (1) | WO1995031555A1 (de) |
| ZA (1) | ZA953961B (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9409962D0 (en) * | 1994-05-18 | 1994-07-06 | Smithkline Beecham Biolog | Novel compounds |
| NZ506602A (en) * | 1998-03-09 | 2003-02-28 | Smithkline Beecham Biolog S | Combined vaccine compositions against hepatitis B virus and herpes simplex virus and possibly also epstein bar virus, hepatitis A & C viruses, human papilloma virus, varicella zoster virus, human cytomegalovirus, and toxoplasma gondii |
| GB9921146D0 (en) * | 1999-09-07 | 1999-11-10 | Smithkline Beecham Biolog | Novel composition |
| WO2006047176A1 (en) * | 2004-10-22 | 2006-05-04 | Cargill, Incorporated | Process for the production of maltodextrins and maltodextrins |
| TWI457133B (zh) | 2005-12-13 | 2014-10-21 | Glaxosmithkline Biolog Sa | 新穎組合物 |
| WO2010074126A1 (ja) * | 2008-12-25 | 2010-07-01 | 財団法人化学及血清療法研究所 | 組換え鶏伝染性コリーザワクチン及びその製造方法 |
| US8802106B2 (en) | 2009-10-30 | 2014-08-12 | The Administrators Of The Tulane Educational Fund | Peptide compositions and methods for inhibiting herpesvirus infection |
| ES2635014T3 (es) | 2010-10-15 | 2017-10-02 | Glaxosmithkline Biologicals S.A. | Antígeno gB del citomegalovirus |
| US9950056B2 (en) * | 2013-09-24 | 2018-04-24 | Duke University | Compositions, methods and kits for eliciting an immune response |
| US10611800B2 (en) | 2016-03-11 | 2020-04-07 | Pfizer Inc. | Human cytomegalovirus gB polypeptide |
| US11629172B2 (en) | 2018-12-21 | 2023-04-18 | Pfizer Inc. | Human cytomegalovirus gB polypeptide |
| US11857622B2 (en) | 2020-06-21 | 2024-01-02 | Pfizer Inc. | Human cytomegalovirus GB polypeptide |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5171568A (en) * | 1984-04-06 | 1992-12-15 | Chiron Corporation | Recombinant herpes simplex gb-gd vaccine |
| DE3751772T2 (de) * | 1986-10-20 | 1996-12-05 | Chiron Corp | Impfstoff zur behandlung von hsv |
| DE68929478T2 (de) * | 1988-01-29 | 2004-04-29 | Aventis Pasteur | Rekombinante CMV-Neutralisierungsproteine |
| GB9409962D0 (en) * | 1994-05-18 | 1994-07-06 | Smithkline Beecham Biolog | Novel compounds |
-
1994
- 1994-05-18 GB GB9409962A patent/GB9409962D0/en active Pending
-
1995
- 1995-05-11 KR KR1019960706516A patent/KR970703428A/ko not_active Application Discontinuation
- 1995-05-11 AT AT95919447T patent/ATE293697T1/de active
- 1995-05-11 PL PL95317235A patent/PL317235A1/xx unknown
- 1995-05-11 BR BR9507728A patent/BR9507728A/pt not_active Application Discontinuation
- 1995-05-11 AT AT05075216T patent/ATE483809T1/de not_active IP Right Cessation
- 1995-05-11 HU HU9603163A patent/HU9603163D0/hu unknown
- 1995-05-11 JP JP7529352A patent/JPH10500009A/ja active Pending
- 1995-05-11 ES ES05075216T patent/ES2353134T3/es not_active Expired - Lifetime
- 1995-05-11 WO PCT/EP1995/001800 patent/WO1995031555A1/en active IP Right Grant
- 1995-05-11 EP EP95919447A patent/EP0759995B1/de not_active Expired - Lifetime
- 1995-05-11 DE DE69536112T patent/DE69536112D1/de not_active Expired - Lifetime
- 1995-05-11 DE DE69534162T patent/DE69534162T2/de not_active Expired - Lifetime
- 1995-05-11 CA CA002190529A patent/CA2190529A1/en not_active Abandoned
- 1995-05-11 US US08/737,691 patent/US5889168A/en not_active Expired - Lifetime
- 1995-05-11 DK DK95919447T patent/DK0759995T3/da active
- 1995-05-11 SI SI9530717T patent/SI0759995T1/xx unknown
- 1995-05-11 EP EP05075216A patent/EP1529845B1/de not_active Expired - Lifetime
- 1995-05-11 AU AU25271/95A patent/AU2527195A/en not_active Abandoned
- 1995-05-11 ES ES95919447T patent/ES2239758T3/es not_active Expired - Lifetime
- 1995-05-11 PT PT95919447T patent/PT759995E/pt unknown
- 1995-05-16 ZA ZA953961A patent/ZA953961B/xx unknown
- 1995-05-18 US US08/443,642 patent/US5739292A/en not_active Expired - Lifetime
-
1996
- 1996-11-15 NO NO964874A patent/NO964874D0/no unknown
-
1997
- 1997-12-23 US US08/997,211 patent/US6036959A/en not_active Expired - Fee Related
-
1998
- 1998-12-15 HK HK98113484A patent/HK1012415A1/xx not_active IP Right Cessation
-
2006
- 2006-10-16 CY CY0600028A patent/CY2597B2/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US6036959A (en) | 2000-03-14 |
| DE69536112D1 (de) | 2010-11-18 |
| WO1995031555A1 (en) | 1995-11-23 |
| CA2190529A1 (en) | 1995-11-23 |
| SI0759995T1 (en) | 2005-10-31 |
| GB9409962D0 (en) | 1994-07-06 |
| PL317235A1 (en) | 1997-03-17 |
| CY2597B2 (en) | 2010-03-03 |
| HK1012415A1 (en) | 1999-07-30 |
| EP0759995A1 (de) | 1997-03-05 |
| US5739292A (en) | 1998-04-14 |
| US5889168A (en) | 1999-03-30 |
| ZA953961B (en) | 1996-02-26 |
| EP0759995B1 (de) | 2005-04-20 |
| EP1529845A2 (de) | 2005-05-11 |
| KR970703428A (ko) | 1997-07-03 |
| HU9603163D0 (en) | 1997-01-28 |
| PT759995E (pt) | 2005-07-29 |
| AU2527195A (en) | 1995-12-05 |
| BR9507728A (pt) | 1997-09-23 |
| NO964874L (no) | 1996-11-15 |
| ES2239758T3 (es) | 2005-10-01 |
| EP1529845B1 (de) | 2010-10-06 |
| ATE293697T1 (de) | 2005-05-15 |
| DK0759995T3 (da) | 2005-08-01 |
| JPH10500009A (ja) | 1998-01-06 |
| DE69534162T2 (de) | 2006-03-09 |
| ES2353134T3 (es) | 2011-02-25 |
| NO964874D0 (no) | 1996-11-15 |
| DE69534162D1 (de) | 2005-05-25 |
| EP1529845A3 (de) | 2006-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2597B2 (en) | Fusion glycoprotein from HCMV and HSV | |
| FI920764A0 (fi) | Fusionsproteiner omfattande gm-csf och il-3. | |
| DE69933216D1 (de) | Erythropoietin-analog-menschliches serum-albumin fusionsprotein | |
| ATE449111T1 (de) | Affinitätsreinigung von polypeptid-proteinen auf einer protein a matrix | |
| ATE325882T1 (de) | Polypeptide, die mit alfalfamosaikviralen oder ilarviralen kapsiden fusioniert sind | |
| ATE174628T1 (de) | Expression rekombinanter fusionsproteine in attenuierten bakterien | |
| NO831317L (no) | Fremgangsmaate for fremstilling av funksjonelle menneske-urokinase proteiner. | |
| DK606485D0 (da) | Proteinhydrolysat | |
| FI864552A (fi) | Human-lysozym. | |
| KR950702242A (ko) | 사포린 함유 단백질의 재조합 생산방법(Recombinant production of saporin-containing proteins) | |
| DE69738967D1 (de) | Stabile expression von tripelhelikalen proteinen | |
| DK0406598T3 (da) | Proteinhydrolyse | |
| DE68925304D1 (de) | Minimale Derivatisierung von Proteinen | |
| FI953422A (fi) | Autolysoivia fuusioproteiineja hyväksikäyttävät ilmentämisjärjestelmät ja uusi pelkistävä polypeptidi | |
| PT90359A (pt) | Expressao da proteina pres2 da hepatite b em leveduras metilotroficas | |
| FI885328A0 (fi) | Foerfarande foer selektiv spaltning av fusionsproteiner. | |
| DK284489A (da) | Fusionsproteiner | |
| FI944997A0 (fi) | Parannettu rekombinantti-proteiinien tuotanto | |
| FI942467A (fi) | Proteesivakaat proteiinit | |
| DE69123089D1 (de) | Amin-angereicherte Proteine | |
| DE3580590D1 (de) | Herstellungsverfahren fuer heterogene proteine. | |
| DK63489A (da) | Fremgangsmaade til spaltning af fusionsproteiner |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |